Cefacetrile
Appearance
(Redirected from Cephacetrile)
Clinical data | |
---|---|
Trade names | Celospor, Celtol, Cristacef |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Intravenous, intramuscular, intramammary |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 23 to 38% |
Elimination half-life | 1.2 hours |
Excretion | Renal (72%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.030.449 |
Chemical and physical data | |
Formula | C13H13N3O6S |
Molar mass | 339.32 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Cefacetrile (INN, also spelled cephacetrile) is a broad-spectrum first generation cephalosporin antibiotic effective in gram-positive and gram-negative bacterial infections. It is a bacteriostatic antibiotic.[1][2] Cefacetrile is marketed under the trade names Celospor, Celtol, and Cristacef,[3] and as Vetimast for the treatment of mammary infections in lactating cows.[2]
Synthesis
[edit]It was made by reacting 7-ACA (7-aminocephalosporanic acid) with cyanoacetyl chloride in the presence of tributylamine.[citation needed]
References
[edit]- ^ "Cefacetrile Summary Report" (PDF). European Medicines Agency, Committee for Veterinary Medicinal Products. 1998. Archived from the original (PDF) on 2020-05-26. Retrieved 2012-01-25.
- ^ a b Haberfeld H, ed. (2007). Austria-Codex (in German) (2007/2008 ed.). Vienna: Österreichischer Apothekerverlag. ISBN 978-3-85200-183-8.
- ^ Horiuchi N, Oyakawa Y, Oka R, Fujiwara T (October 1980). "[Clinical evaluation of cephacetrile (Celtol) for respiratory infections (author's transl)]". The Japanese Journal of Antibiotics. 33 (10): 1145–55. PMID 7206219.